Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Biodesix (BDSX) stocks in Canada

Learn how to easily invest in Biodesix stocks.

Biodesix is a diagnostics & research business based in the US. Biodesix stocks (BDSX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11 – a decrease of 11.34% over the previous week. Biodesix employs 200 staff and has a trailing 12-month revenue of around $74.3 million.

How to buy shares in Biodesix

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BDSX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biodesix stock price (NASDAQ:BDSX)

Use our graph to track the performance of BDSX stocks over time.

Biodesix shares at a glance

Information last updated 2022-01-17.
Latest market close$4.38
52-week range$4.02 - $31.99
50-day moving average $5.77
200-day moving average $10.24
Wall St. target price$16.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.36

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Biodesix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Biodesix price performance over time

Historical closes compared with the close of $4.38 from 2022-01-19

1 week (2022-01-13) -11.34%
1 month (2021-12-20) -0.68%
3 months (2021-10-20) -43.26%
6 months (2021-07-20) -58.68%
1 year (2021-01-20) -85.97%
2 years (2020-01-16) N/A
3 years (2019-01-16) N/A
5 years (2017-01-16) N/A

Biodesix financials

Revenue TTM $74.3 million
Gross profit TTM $23.6 million
Return on assets TTM -27.86%
Return on equity TTM -1089.34%
Profit margin -46.31%
Book value $0.59
Market capitalisation $146.2 million

TTM: trailing 12 months

Biodesix share dividends

We're not expecting Biodesix to pay a dividend over the next 12 months.

Biodesix overview

Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests that provide physicians with timely results to facilitate treatment decisions. It also provides Bio-Rad SARS-CoV-2 ddPCR test, which is designed to detect the presence of infection by the SARS-CoV-2 virus; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. In addition, the company offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site